(Q36811847)

English

Serious adverse events with infliximab: analysis of spontaneously reported adverse events

scientific article published on 4 May 2007

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

16 August 2017

Serious adverse events with infliximab: analysis of spontaneously reported adverse events (English)

1 reference

stated in

Europe PubMed Central

16 August 2017

2

1 reference

stated in

Europe PubMed Central

16 August 2017

Richard A Hansen

1

0 references

Robert S Sandler

series ordinal

4

object named as

Robert S Sandler

1 reference

stated in

Europe PubMed Central

16 August 2017

Gregory E Powell

3

1 reference

stated in

Europe PubMed Central

PubMed ID

17481964

retrieved

16 August 2017

language of work or name

English

0 references

publication date

4 May 2007

1 reference

stated in

Europe PubMed Central

16 August 2017

Clinical Gastroenterology and Hepatology

1 reference

stated in

Europe PubMed Central

16 August 2017

5

1 reference

stated in

Europe PubMed Central

16 August 2017

6

1 reference

stated in

Europe PubMed Central

16 August 2017

729-735

1 reference

stated in

Europe PubMed Central

PubMed ID

17481964

retrieved

16 August 2017

Identifiers

DOI

10.1016/J.CGH.2007.02.016

1 reference

stated in

Europe PubMed Central

16 August 2017

1 reference

Europe PubMed Central

PubMed ID

17481964

retrieved

16 August 2017

(Q36811847)

Serious adverse events with infliximab: analysis of spontaneously reported adverse events

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)